119 related articles for article (PubMed ID: 38328847)
1. TUMOR MICROENVIRONMENT-ASSOCIATED miR-7-5p, miR-19a-3p, AND miR-23b-3p EXPRESSION IN PROSTATE CANCER WITH DIFFERENT PROGRESSION RISK.
Borikun T; Mushii O; Pavlova A; Burda T; Zadvornyi T
Exp Oncol; 2024 Feb; 45(4):432-442. PubMed ID: 38328847
[TBL] [Abstract][Full Text] [Related]
2. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.
Cochetti G; Poli G; Guelfi G; Boni A; Egidi MG; Mearini E
Onco Targets Ther; 2016; 9():7545-7553. PubMed ID: 28008272
[TBL] [Abstract][Full Text] [Related]
3. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer.
Tinay I; Tan M; Gui B; Werner L; Kibel AS; Jia L
Prostate; 2018 Sep; 78(12):927-937. PubMed ID: 29748958
[TBL] [Abstract][Full Text] [Related]
4. Activin A regulates microRNAs and gene expression in LNCaP cells.
Ottley EC; Nicholson HD; Gold EJ
Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
[TBL] [Abstract][Full Text] [Related]
5. Serum Levels of miR-223-3p and miR-223-5p in Prostate Diseases.
Dülgeroğlu Y; Eroğlu O
Microrna; 2020; 9(4):303-309. PubMed ID: 33155933
[TBL] [Abstract][Full Text] [Related]
6. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
Pan MZ; Song YL; Gao F
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8795-8805. PubMed ID: 31696466
[TBL] [Abstract][Full Text] [Related]
7. Challenges in Cancer Biomarker Discovery Exemplified by the Identification of Diagnostic MicroRNAs in Prostate Tissues.
Ambrozkiewicz F; Karczmarski J; Kulecka M; Paziewska A; Cybulska M; Szymanski M; Dobruch J; Antoniewicz A; Mikula M; Ostrowski J
Biomed Res Int; 2020; 2020():9086829. PubMed ID: 32462034
[TBL] [Abstract][Full Text] [Related]
8. miR-490-3p modulates the progression of prostate cancer through regulating histone deacetylase 2.
Fan H; Zhang YS
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):539-546. PubMed ID: 30720161
[TBL] [Abstract][Full Text] [Related]
9. Mast cells as a tumor microenvironment factor associated with the aggressiveness of prostate cancer.
Zadvornyi T; Lukianova N; Borikun T; Tymoshenko A; Mushii O; Voronina O; Vitruk I; Stakhovskyi E; Chekhun V
Neoplasma; 2022 Dec; 69(6):1490-1498. PubMed ID: 36591806
[TBL] [Abstract][Full Text] [Related]
10. Human papilloma virus (HPV) and prostate cancer (PCa): The potential role of HPV gene expression and selected cellular MiRNAs in PCa development.
Khatami A; Nahand JS; Kiani SJ; Khoshmirsafa M; Moghoofei M; Khanaliha K; Tavakoli A; Emtiazi N; Bokharaei-Salim F
Microb Pathog; 2022 May; 166():105503. PubMed ID: 35398468
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-19a-3p suppresses invasion and metastasis of prostate cancer via inhibiting SOX4.
Feng YG; Zhao JF; Xiao L; Rao WY; Ran C; Xiao YH
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6245-6251. PubMed ID: 30338791
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding TUG1 accelerates prostate cancer progression through regulating miR-128-3p/YES1 axis.
Hao SD; Ma JX; Liu Y; Liu PJ; Qin Y
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):619-632. PubMed ID: 32016963
[TBL] [Abstract][Full Text] [Related]
13. Specific Autoantibodies and Clinical Phenotypes Correlate with the Aberrant Expression of Immune-Related MicroRNAs in Dermatomyositis.
Ye L; Zuo Y; Yang H; Li W; Peng Q; Lu X; Wang G; Shu X
J Immunol Res; 2019; 2019():2927061. PubMed ID: 30915368
[TBL] [Abstract][Full Text] [Related]
14. TGF-β1-regulated miR-3691-3p targets
Hu YM; Lou XL; Liu BZ; Sun L; Wan S; Wu L; Zhao X; Zhou Q; Sun MM; Tao K; Zhang YS; Wang SL
Asian J Androl; 2021; 23(2):188-196. PubMed ID: 33159025
[TBL] [Abstract][Full Text] [Related]
15. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses.
Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M
Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512
[TBL] [Abstract][Full Text] [Related]
16. Investigation of miR-26a-5p and miR-19a-3p expression levels in angiographically confirmed coronary artery disease.
Coban N; Erkan AF; Ozuynuk-Ertugrul AS; Ekici B
Acta Cardiol; 2023 Oct; 78(8):945-956. PubMed ID: 37376990
[TBL] [Abstract][Full Text] [Related]
17. A tissue miRNA expression pattern is associated with disease aggressiveness of localized prostate cancer.
Juracek J; Madrzyk M; Stanik M; Ruckova M; Trachtova K; Malcikova H; Lzicarova E; Barth DA; Pichler M; Slaby O
Prostate; 2023 Mar; 83(4):340-351. PubMed ID: 36478451
[TBL] [Abstract][Full Text] [Related]
18. Identification of miR-1-3p, miR-143-3p and miR-145-5p association with bone metastasis of Gleason 3+4 prostate cancer and involvement of LASP1 regulation.
Guo H; Zhao J; Li X; Sun F; Qin Y; Yang X; Xiong X; Yin Q; Wang X; Gao L; Jiao M; Hu J; Han B
Mol Cell Probes; 2023 Apr; 68():101901. PubMed ID: 36791996
[TBL] [Abstract][Full Text] [Related]
19. Allicin protects against myocardial I/R by accelerating angiogenesis via the miR-19a-3p/PI3K/AKT axis.
Liu M; Yang P; Fu D; Gao T; Deng X; Shao M; Liao J; Jiang H; Li X
Aging (Albany NY); 2021 Oct; 13(19):22843-22855. PubMed ID: 34607973
[TBL] [Abstract][Full Text] [Related]
20. Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.
Chiyomaru T; Yamamura S; Fukuhara S; Hidaka H; Majid S; Saini S; Arora S; Deng G; Shahryari V; Chang I; Tanaka Y; Tabatabai ZL; Enokida H; Seki N; Nakagawa M; Dahiya R
PLoS One; 2013; 8(3):e58929. PubMed ID: 23554959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
